FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma, Inc. | 079937015 | 70092-563 | 70092-563-43 | Ketamine Hydrochloride | 20 mg/2 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-120 | 70092-120-43 | Ketamine Hydrochloride | 50 mg/1 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 036662848 | Ketamine Hydrochloride | 75000 mg/1500 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Ketamine Hydrochloride | 50 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Ketamine Hydrochloride | 50 mg/5 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Ketamine Hydrochloride | 20 mg/2 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | Ketorolac Tromethamine; Epinephrine; Clonidine Hydrochloride; Ropivacaine Hydrochloride | 900 mg/3000 mL; 15 mg/3000 mL; 2.4 mg/3000 mL; 7380 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-433 | 70092-433-50 | Ketorolac Tromethamine; Epinephrine; Clonidine Hydrochloride; Ropivacaine Hydrochloride | 15 mg/50 mL; .25 mg/50 mL; .04 mg/50 mL; 123 mg/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 036662848 | Labetalol | 15000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Labetalol Hydrochloride | 20 mg/4 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Lidocaine | 60000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Lidocaine | 3334 mg/2000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Lidocaine | 10 mg/100 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Lidocaine | 30000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Lidocaine | 100 mg/10 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 036662848 | Lidocaine | 100 mg/5 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | Lidocaine Hydrochloride | 27300 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-443 | 70092-443-43 | Lidocaine Hydrochloride | 9.1 mg/1 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-175 | 70092-175-46 | Lidocaine Hydrochloride | 91 mg/10 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-229 | 70092-229-43 | Atropine Sulfate | 1 mg/2.5 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-611 | 70092-611-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-612 | 70092-612-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-658 | 70092-658-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Lidocaine Hydrochloride; Epinephrine | 30000 mg/3000 mL; 30000 ug/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-662 | 70092-662-43 | Lidocaine Hydrochloride; Epinephrine | 15 mg/3 mL; 30 ug/3 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-691 | 70092-691-44 | Lidocaine Hydrochloride; Epinephrine | 30 mg/3 mL; 30 ug/3 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-690 | 70092-690-44 | Lidocaine Hydrochloride; Epinephrine | 15 mg/3 mL; 30 ug/3 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Lidocaine Hydrochloride; Epinephrine | 15000 mg/3000 mL; 30000 ug/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-663 | 70092-663-43 | Lidocaine Hydrochloride; Epinephrine | 30 mg/3 mL; 30 ug/3 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-147 | 70092-147-03 | Lidocaine Hydrochloride; Potassium Chloride | 10 mg/100 mL; 10 meq/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-161 | 70092-161-43 | Methadone Hydrochloride | 1 mg/1 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-310 | 70092-310-46 | Methohexital Sodium | 100 mg/10 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-418 | 70092-418-36 | Midazolam Hydrochloride | 100 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Midazolam Hydrochloride | 3000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-522 | 70092-522-35 | Morphine Sulfate | 50 mg/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Morphine Sulfate | 3000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | Morphine Sulfate | 250 mg/500 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-521 | 70092-521-74 | Morphine Sulfate | 50 mg/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-523 | 70092-523-50 | Morphine Sulfate | 50 mg/50 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 036662848 | Morphine Sulfate | 3000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-519 | 70092-519-48 | Morphine Sulfate | 30 mg/30 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 036662848 | Morphine Sulfate | 30 mg/30 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-517 | 70092-517-43 | Morphine Sulfate | 1 mg/1 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | Morphine Sulfate | 1500 mg/1500 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| QuVa Pharma, Inc. | 079937015 | 70092-520 | 70092-520-49 | Morphine Sulfate | 30 mg/30 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-132 | 70092-132-43 | Morphine Sulfate | 1 mg/2 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-380 | 70092-380-36 | Morphine Sulfate | 100 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-518 | 70092-518-75 | Morphine Sulfate | 100 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-133 | 70092-133-43 | Morphine Sulfate | 2 mg/2 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 036662848 | Neostigmine | 5 mg/5 mL | 2025-2 | source_no_ndc | 2026-08-12 |